EX-10.3
from 8-K
35 pages
This Note Amends and Restates That Certain 8% Secured Convertible Promissory Note Dated April 5, 2007, in the Original Principal Amount of $10,000,000 (The “April 2007 Note”), and That Certain 12% Amended and Restated Convertible Promissory Note Dated April 24, 2008 in the Original Principal Amount of $15,000,000 (The “April 2008 Note” and Together With the April 2007 Note, the “Prior Notes”) Issued by the Undersigned to the Order of Whitebox Pharmaceutical Growth Fund, Ltd. (The “Holder”). It Is Expressly Intended, Understood and Agreed That This Note and the Accompanying $10,000,000 Second Amended and Restated 12%
12/34/56
EX-10.2
from 8-K
35 pages
This Note Amends and Restates That Certain 8% Secured Convertible Promissory Note Dated April 5, 2007, in the Original Principal Amount of $10,000,000 (The “April 2007 Note”), and That Certain 12% Amended and Restated Convertible Promissory Note Dated April 24, 2008 in the Original Principal Amount of $15,000,000 (The “April 2008 Note” and Together With the April 2007 Note, the “Prior Notes”) Issued by the Undersigned to the Order of Whitebox Pharmaceutical Growth Fund, Ltd. (The “Holder”). It Is Expressly Intended, Understood and Agreed That This Note and the Accompanying $5,000,000 Second Amended and Restated 12%
12/34/56